The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma: a judicious option?
Th. Delaunoit, M. Ducreux, V. Boige, C. Dromain, J.-C. Sabourin, P. Duvillard, M. Schlumberger, T. de Baere, P. Rougier, P. Ruffie, D. Elias, P. Lasser, E. BaudinVolume:
40
Year:
2004
Language:
english
Pages:
521
DOI:
10.1016/j.ejca.2003.09.035
File:
PDF, 165 KB
english, 2004